NYSE$LH

Laboratory Corp Of America Holdings · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

LabCorp's Q3 2020 earnings were announced, demonstrating significant revenue and EPS growth.

LabCorp announced strong Q3 2020 results, with revenue increasing by 33.0% to $3.9 billion and diluted EPS rising to $7.17. The company's performance was driven by COVID-19 testing and improvements in its base business, leading to increased operating income and free cash flow. LabCorp also decided to return all money received from the CARES Act Provider Relief Funds due to its improved financial outlook.

  • Q3 revenue increased to $3.9 billion, a 33.0% rise from the previous year.
  • Diluted EPS for Q3 reached $7.17, significantly up from $2.25 last year; adjusted EPS was $8.41, compared to $2.90 last year.
  • Q3 free cash flow grew to $709 million, an increase from $363 million in the prior year.
  • LabCorp will return all money received from the CARES Act Provider Relief Funds due to improved financial performance.

Headline financials

Total Revenue

$3.9B

Previous: $2.93B+33.0%
EPS (adj)

$8.41

Previous: $2.90+190.0%
TTM Net Orders

$6.13B

No prior period
TTM Book-to-Bill

1.31

No prior period
Backlog

$12.5B

No prior period
Capital Expenditures

-$282M

Previous: -$272M-3.8%
Free Cash Flow

$421M

Previous: -$51.3M+920.9%
Net Income

$703M

Previous: $221M+218.7%
Operating Income

$1.05B

Previous: $340M+208.1%
Gross Profit

$1.56B

Previous: $817M+90.8%
Cash & Equivalents

$667M

Previous: $361M+84.8%
Total Assets

$18.7B

Previous: $17.8B+5.0%
Stock-Based Comp

$27.2M

Previous: $31.5M-13.7%

Revenue & EPS history

LabCorp · Revenue · Quarterly

$3.9B

Q3 2020+33%vs Q3 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

LabCorp · $3.94B total across 2 segments · Q3 2020

  • Diagnostics Laboratories
    $2.7B+53.4%
  • Biopharma Laboratory Services
    $1.24B+5.1%

Forward guidance

Given the continued unpredictability pertaining to the COVID-19 pandemic, there are a wide-range of potential financial outcomes. As a result, the Company continues to not provide 2020 guidance.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-0.3%

Avg return

Earnings day

-0.6%

Avg return

5 days after

-0.9%

Avg return

30 days after

48%

35 / 73 earnings

Positive

+9.5%

Q2 2024

Best reaction

-10.4%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.0%+0.0%+1.3%
Q4 2025-2.1%+0.0%-6.6%
Q3 2025-5.7%-7.9%-2.7%
Q2 2025-0.5%+1.2%+2.0%
Q1 2025+4.7%+7.9%+7.5%
Q4 2024-0.9%-1.9%+1.2%
Q3 2024+4.0%+3.7%+9.0%
Q2 2024+9.5%+4.8%+6.7%
Q1 2024-4.6%-3.2%-4.0%
Q4 2023-5.0%-5.5%-8.3%
Q3 2023+0.6%+1.0%+7.6%
Q2 2023-1.9%-2.4%-3.0%
Q1 2023-4.6%-2.5%-8.2%
Q4 2022+3.2%-0.4%-14.1%
Q3 2022-2.5%-3.2%+5.0%
Q2 2022+5.1%+1.2%-8.1%
Q1 2022-5.0%-3.1%+1.9%
Q4 2021-1.9%-6.0%-5.7%
Q3 2021+2.3%+2.0%+3.1%
Q2 2021+4.6%+6.0%+6.1%
Q1 2021+1.2%+4.1%+4.5%
Q4 2020+4.0%+3.1%+4.1%
Q3 2020+1.0%-1.1%-2.7%
Q2 2020-3.3%-4.2%-13.4%
Q1 2020-6.5%-10.4%-0.4%
Q4 2019+4.1%+1.8%-19.5%
Q3 2019-2.0%-2.3%+0.4%
Q2 2019-6.5%-4.2%-6.9%
Q1 2019+3.7%+6.1%+5.1%
Q4 2018+2.5%+3.8%+3.7%
Q3 2018-7.1%-6.2%-4.1%
Q2 2018-5.4%-6.4%-5.3%
Q1 2018+3.9%+2.8%+9.7%
Q4 2017+3.9%+3.0%+5.9%
Q3 2017+1.7%+2.2%+0.2%
Q2 2017+2.0%+1.3%-1.4%
Q1 2017-4.1%-3.1%-1.9%
Q4 2016+2.4%+2.4%+5.4%
Q3 2016-10.4%-9.4%-7.9%
Q2 2016+0.4%+1.2%-1.4%
Q1 2016+4.1%
Q4 2015+2.8%
Q3 2015+7.8%
Q2 2015+3.8%
Q1 2015-2.7%
Q4 2014+4.9%
Q3 2014+3.5%
Q2 2014-0.5%
Q1 2014-0.7%
Q4 2013+1.1%
Q3 2013-3.2%
Q2 2013+0.0%
Q1 2013+0.7%
Q4 2012-1.7%
Q3 2012-4.0%
Q2 2012-9.0%
Q1 2012-3.4%
Q4 2011+2.2%
Q3 2011-6.6%
Q2 2011-0.6%
Q1 2011+1.4%
Q4 2010-0.2%
Q4 2007-0.2%
Q3 2010+1.6%
Q2 2010+0.9%
Q1 2009+1.8%
Q1 2010+1.6%
Q4 2009-0.4%
Q2 2008-1.6%
Q3 2009-1.6%
Q3 2008-1.6%
Q4 2008-1.4%
Q2 2009-1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro